• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Estimating tubular damage for predicting progression of chronic kidney disease-what are the implications for clinical practice and public health?

作者信息

Nowak Christoph, Ärnlöv Johan

机构信息

Department of Neurobiology, Care Sciences and Society (NVS), Family Medicine and Primary Care Unit, Karolinska Institutet, Huddinge, Sweden.

School of Health and Social Studies, Dalarna University, Falun, Sweden.

出版信息

Nephrol Dial Transplant. 2021 Sep 27;36(10):1769-1770. doi: 10.1093/ndt/gfab009.

DOI:10.1093/ndt/gfab009
PMID:33459789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8476074/
Abstract
摘要

相似文献

1
Estimating tubular damage for predicting progression of chronic kidney disease-what are the implications for clinical practice and public health?评估肾小管损伤以预测慢性肾脏病的进展——对临床实践和公共卫生有何影响？
Nephrol Dial Transplant. 2021 Sep 27;36(10):1769-1770. doi: 10.1093/ndt/gfab009.
2
[Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease].[慢性肾脏病肾小管损伤和间质纤维化生物标志物的鉴定]
Yakugaku Zasshi. 2017;137(11):1355-1360. doi: 10.1248/yakushi.17-00150.
3
Tubular secretion in chronic kidney disease staging: a new proposal.慢性肾脏病分期中的肾小管分泌：一项新提议。
Int Urol Nephrol. 2017 Nov;49(11):2087-2089. doi: 10.1007/s11255-017-1673-0. Epub 2017 Aug 3.
4
Genetically-instrumented public health: facing obesity to prevent chronic kidney disease.基因手段助力公共卫生：应对肥胖以预防慢性肾病
Cardiovasc Res. 2022 Dec 9;118(15):3013-3015. doi: 10.1093/cvr/cvac168.
5
[Chronic kidney disease--a public health problem?].[慢性肾脏病——一个公共卫生问题？]
Lakartidningen. 2013;110(21):1018-20.
6
Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.急性肾损伤：肾小管标志物与慢性肾脏病及终末期肾衰竭风险
Blood Purif. 2016;41(1-3):144-50. doi: 10.1159/000441269. Epub 2016 Jan 15.
7
Progression of chronic kidney disease in children - role of glomerular hemodynamics and interstitial fibrosis.儿童慢性肾脏病的进展 - 肾小球血流动力学和间质纤维化的作用。
Curr Opin Pediatr. 2018 Apr;30(2):220-227. doi: 10.1097/MOP.0000000000000594.
8
Biomarkers for Chronic Kidney Disease Associated with High Salt Intake.高盐摄入相关慢性肾脏病的生物标志物。
Int J Mol Sci. 2017 Sep 30;18(10):2080. doi: 10.3390/ijms18102080.
9
Tubular cell damage may be the earliest sign of renal extrahepatic manifestation caused by Hepatitis C.管状细胞损伤可能是丙型肝炎引起的肝外肾脏表现的最早迹象。
PLoS One. 2021 May 7;16(5):e0251392. doi: 10.1371/journal.pone.0251392. eCollection 2021.
10
Role of Renal Hypoxia in the Progression From Acute Kidney Injury to Chronic Kidney Disease.肾脏缺氧在急性肾损伤向慢性肾脏病进展中的作用。
Semin Nephrol. 2019 Nov;39(6):567-580. doi: 10.1016/j.semnephrol.2019.10.006.

本文引用的文献

1
Urinary excretion of epidermal growth factor and rapid loss of kidney function.尿表皮生长因子排泄与肾功能快速丧失。
Nephrol Dial Transplant. 2021 Sep 27;36(10):1882-1892. doi: 10.1093/ndt/gfaa208.
2
Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?基于生物标志物的急性肾损伤风险评估：是否到了临床实施的时机？
Ann Lab Med. 2021 Jan;41(1):1-15. doi: 10.3343/alm.2021.41.1.1. Epub 2020 Aug 25.
3
Molecular nephrology: types of acute tubular injury.分子肾病学：急性肾小管损伤的类型。
Nat Rev Nephrol. 2019 Oct;15(10):599-612. doi: 10.1038/s41581-019-0184-x. Epub 2019 Aug 22.
4
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.尿标志物与管状损伤相关，在伴有慢性肾病的收缩压干预试验参与者中与死亡率相关，但与心血管风险无关。
Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.
5
State-Level Awareness of Chronic Kidney Disease in the U.S.美国各州对慢性肾脏病的认知程度
Am J Prev Med. 2017 Sep;53(3):300-307. doi: 10.1016/j.amepre.2017.02.015. Epub 2017 Apr 11.
6
Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.肾小管损伤的尿液生物标志物并不能改善预测慢性肾脏病进展的临床模型。
Kidney Int. 2017 Jan;91(1):196-203. doi: 10.1016/j.kint.2016.09.003. Epub 2016 Oct 28.
7
Prevalence and recognition of chronic kidney disease in Stockholm healthcare.斯德哥尔摩医疗保健中慢性肾脏病的患病率与认知情况
Nephrol Dial Transplant. 2016 Dec;31(12):2086-2094. doi: 10.1093/ndt/gfw354. Epub 2016 Oct 13.
8
Variation in Patients' Awareness of CKD according to How They Are Asked.根据询问方式不同，患者对慢性肾脏病的知晓情况存在差异。
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1566-1573. doi: 10.2215/CJN.00490116. Epub 2016 Jun 23.
9
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.尿肽组学在糖尿病肾病的啮齿动物模型中突出了表皮生长因子作为 2 型糖尿病患者肾脏恶化的生物标志物。
Kidney Int. 2016 May;89(5):1125-1135. doi: 10.1016/j.kint.2016.01.015. Epub 2016 Mar 7.
10
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.基于组织转录组学驱动鉴定表皮生长因子作为慢性肾脏病生物标志物
Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.